Background: Patients with obstructive sleep apnea syndrome (OSAS) often complain of dryness of mouth and throat prior to and during nasal continuous positive airway pressure (nCPAP). It is believed that this is due to mouth breathing (MB). However, the association between mouth breathing and apneas/hypopneas and the effect of CPAP on MB has not been studied. Objectives: The purpose of the present study was, therefore, to assess the frequency and duration of episodes of MB prior to and during treatment with nCPAP. Methods: MB was recorded prior to and during nCPAP with a closely fitting mouth mask connected to a pneumotachograph and nasal flow was measured via nasal prongs. MB episodes were expressed as the number of events divided by total sleep time × 60, to give the MB event index per hour of sleep. MB time divided by total sleep time × 60 was calculated in minutes to get the MB time index per hour of sleep. Patients: Eleven male patients with OSAS (mean age 57.9 ± 8.3 years, body mass index 30.2 ± 3.8) were recruited to the study. Results: Prior to nCPAP, the apnea/hypopnea index was 55.8 ± 26 and decreased during nCPAP to 8.0 ± 3.4. The lowest SaO2 measured was 82.9 ± 4.7%, and increased to 87.5 ± 2.7% under nCPAP. The mean nCPAP was 7.8 ± 1.6 cm H2O. MB event index per hour of sleep decreased from 35.2 ± 19.7 prior to treatment to 5.0 ± 5.2 under nCPAP (p < 0.01). In 52.2 ± 27.4% of obstructive respiratory events, MB started at the end of an apnea/hypopnea episode, decreasing to 8.5 ± 12.5% with nCPAP treatment. MB time index per hour of sleep was reduced from 13.5 ± 10.2 min prior to treatment to 4.6 ± 5.5 min under nCPAP (p < 0.05). Conclusions: In OSAS patients, MB episodes often appear at the termination of an apnea/hypopnea episode. In many cases, MB episodes can be markedly reduced by nCPAP treatment. When patients on nCPAP complain of dry mouth, appropriate measurements should be performed to verify MB.

Keywords:
Obstructive sleep apnea, Mouth leak, Arousal, Nasal continuous positive airway pressure
1.
Gleeson K, Zwillich CW, Braier K, White DP: Breathing route during sleep. Am Rev Respir Dis 1986;134:115–120.
2.
Hernandez L, Ballester E, Reolid A, Fornas C, Rodriguez Roisin R, Montserrat JM: Breathing route detected by conventional devices (thermistor). Am J Respir Crit Care Med 1997;155:A130.
3.
Bachour A, Maasilta P: Mouth breathing compromises adherence to nasal continuous positive airway pressure therapy. Chest 2004;126:1248–1254.
4.
BaHammam A: Comparison of nasal prong pressure and thermistor measurements for detecting respiratory events during sleep. Respiration 2004;71:385–390.
5.
Thurnheer R, Xiabin X, Bloch KE: Accuracy of nasal cannula pressure recordings for assessment of ventilation during sleep. Am J Respir Crit Care Med 2001;164:1914–1919.
6.
Hayes MJ, McGregor FB, Roberts DN, Schroter RC, Pride NB: Continuous nasal positive airway pressure with a mouth leak: effect on nasal mucosal blood flux and nasal geometry. Thorax 1995;50:1179–1182.
7.
Richards GN, Cistulli PA, Ungar G, Berthon-Jones M, Sullivan CE: Mouth leak with nasal continuous positive airway pressure increases nasal airway resistance. Am J Respir Crit Care Med 1996;154:182–186.
8.
Rechtschaffen A, Kales A (eds): A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects. Publication No. 204. Washington, National Institutes of Health, 1968.
9.
Bonnet M, Carley M, Carskadon PE, Guilleminault R, et al: EEG arousals: scoring rules and examples: a preliminary report from the Sleep Disorders Atlas Task Force of the American Sleep Disorders Association. Sleep 1992;15:173–184.
10.
Hollowell DE, Suratt PM: Mandible position and activation of submental and masseter muscles during sleep. J Appl Physiol 1991;71:2267–2273.
11.
Meurice JC, Marc I, Carrier G, Series F: Effects of mouth opening on upper airway collapsibility in normal sleeping subjects. Am J Respir Crit Care Med 1996;153:255–259.
12.
Akre H, Skatved O, Oeverland B, Borgersen AK: Internal thermistors in differentiating between oral and nasal breathing during sleep. Acta Otolaryngol 1999;119:934–938.
13.
Badia JR, Farre RO, John Kimoff R, Ballester E, Hernandez L, Rotger M, Navajas D, Montserrat JM: Clinical application of the forced oscillation technique for CPAP titration in the sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med 1999;160:1550–1554.
14.
Teschler H, Stampa J, Ragette R, Konietzko N, Berthon-Jones M: Effect of mouth leak on effectiveness of nasal bilevel ventilatory assistance and sleep architecture. Eur Respir J 1999;14:1251–1257.
15.
Bach JR, Robert D, Leger P, Langevin B: Sleep fragmentation in kyphoscoliotic individuals with alveolar hypoventilation treated by NIPPV. Chest 1995;107:1552–1558.
16.
Meyer TJ, Pressmann MR, BendittJ, McCool FD, et al: Air leaking through the mouth during nocturnal nasal ventilation: effect on sleep quality. Sleep 1997;20:561–569.
17.
Rodenstein DO, Levy P: To sleep, perchance to leak. Eur Respir J 1999;14:1241–1243.
18.
Mortimore IL, Bradley PA, Murray JA, Douglas NJ: Uvulopalatopharyngoplasty may compromise nasal CPAP therapy in sleep apnea syndrome. Am J Respir Crit Care Med 1996;154:1759–1762.
19.
Fietze I, Quispe-BravoS, Hänsch T, Röttig J, Baumann G, Witt Ch: Arousals and sleep stages in patients with obstructive sleep apnoea syndrome: changes under nCPAP treatment. J Sleep Res 1997;6:128–133.
20.
Sugiura T, Noda A, Nakata S, Yasuda Y, Soga T, Miyata S, Nakai S, Koike Y: Influence of nasal resistance on initial acceptance of continuous positive airway pressure in treatment for obstructive sleep apnea syndrome. Respiration 2007;74:56–60.
21.
Mortimore IL, Whittle AT, Douglas NJ: Comparison of nose and face mask CPAP therapy for sleep apnoea. Thorax 1998;53:290–292.
© 2007 S. Karger AG, Basel
2007
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.